After completing the Praedinius Gymnasium (‘Latin School’) in Groningen, the Netherlands, Huib goes to Medical School in Leiden, The Netherlands. For his internships he goes to Rotterdam, The Netherlands. He is registered as a physician, immunologist, radiation safety officer, and radiation oncologist in The Netherlands and the United States. In 1970 Huib marries Francine van Assen.
Huib: “In 1977-78 I worked as a Fogarty Fellow in the Sidney Farber Cancer Center of Harvard University in Boston as a clinical fellow in medical oncology. In the Netherlands I was a staff member of the Laboratory for Experimental Surgery in the Medical Center of Rotterdam, the Primate Center and the Radiobiological Institute of TNO, Rijswijk, The Netherlands and worked part time in the Zuiderziekenhuis and Daniël Den Hoed Clinic in Rotterdam.”
In 1980 Huib and his family immigrated to The United States, where he engages in state of the art bone marrow transplantation, medical oncology, radiation oncology with a special interest in the clinical use of Radiolabeled Immuno Therapy (RIT) in academic institutions in Chicago, Baltimore, Houston, Marshfield and Seattle. Huib is a ‘visiting professor’ in Paris, London, New York and Beirut, Lebanon.
Huib: “I am now fully retired for more than 4 years, but I have never been as busy as I am now. I live at almost 3000meter above sea level in the Rocky Mountains of Colorado. Here I am making new friends, (try to learn how to) lead P2T and write historical fiction about World War II in the Netherlands, working title: ‘War and Peace in the Lowlands’. Occasionally I teach radiobiology to residents in Denver, row frequently with my wife Francine in a double scull on Lake Dillon, take care of our African Art collection and try to add Spanish to my Dutch, English, French and German. My secret cup of gladness is to be the proud father of three children, the father in law of two daughters in Law, one son in law and the grandfather of six grandchildren.
P2T has become my main goal in life. I hope to convince other medical-clinical investigators to engage in their own research again, instead of doing clinical projects for the pharmaceutical industry. Phase 2 studies, ‘open source’, without a for-profit motive, a multidisciplinary approach are the most important components in P2T projects.”